Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $223 | $286 | $28 | $31 |
| Short-Term Investments | $58 | $0 | $124 | $125 |
| Receivables | $78 | $68 | $24 | $3 |
| Inventory | $22 | $22 | $6 | $2 |
| Other Curr. Assets | $12 | $11 | $9 | $5 |
| Total Curr. Assets | $393 | $388 | $190 | $167 |
| Property Plant & Equip (Net) | $10 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $250 | $253 | $59 | $19 |
| Long-Term Investments | $13 | $0 | $0 | $5 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $4 | $101 | $102 |
| Total NC Assets | $278 | $259 | $163 | $128 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $671 | $647 | $353 | $295 |
| Liabilities | – | – | – | – |
| Payables | $15 | $7 | $9 | $9 |
| Short-Term Debt | $2 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $110 | $79 | $55 | $33 |
| Total Curr. Liab. | $127 | $87 | $65 | $43 |
| LT Debt | $316 | $307 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $140 | $130 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $4 | $5 | $0 |
| Total NC Liab. | $319 | $311 | $146 | $132 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $2 | $2 | $3 |
| Total Liabilities | $445 | $398 | $211 | $174 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$644 | -$556 | -$393 | -$257 |
| AOCI | -$0 | $2 | -$0 | -$0 |
| Other Equity | $870 | $803 | $535 | $377 |
| Total Equity | $226 | $249 | $142 | $120 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $671 | $647 | $353 | $295 |
| Net Debt | $95 | $22 | -$26 | -$29 |